ENTITY
Takeda Pharmaceutical

Takeda Pharmaceutical (4502 JP)

292
Analysis
Health CareJapan
Takeda Pharmaceutical Co Ltd focuses on the Research & Development, Manufacturing, Sales and Marketing and Import/Export of Pharmaceutical Drugs. The Company focuses on the following core therapeutic areas: Cardiovascular & Metabolic, Oncology, Central Nervous System, Respiratory & Immunology, General Medicine (Gastrointestinal & Genitourinary) and Vaccine.
more
29 Oct 2019 16:46

Japan - Shorts Cover as Market Rallies

The short notional in the market for the week ended 25 October is US$26.82bn (down by US$0.91bn) with the largest short positions in Itochu Corp...

Logo
525 Views
Share
25 Sep 2019 06:24

Sep Div Date in Japan - Still Interesting, Still Significant

I often label these insights "Tuesday and Wednesday" because it has often been a Tuesday and Wednesday. This autumn's version is called "Thursday...

Logo
676 Views
Share
30 Aug 2019 02:17

JPX Nikkei 400 Rebalance - 2019 Edition Done

The JPX Nikkei 400 Rebalances are, from announcement to end, rarely an interesting event. I was not bullish the Adds vs Deletes performance this...

Logo
621 Views
Share
17 Jul 2019 19:08

Short Selling Is Big in Japan

The Japan Exchange Group (JPX) publishes a daily report that details the short sell activity by market participants. Investors are required to...

Logo
756 Views
Share
19 Jun 2019 13:02

Ascentage Pharma (亚盛医药) IPO: Updates and Thoughts on HQP1351 (3rd Gen Bcr-Abl TKI)

Ascentage Pharma is pre-marketing the USD 200 - 300 million IPO to list in Hong Kong. In our previous insight, we highlight the company's key...

Logo
936 Views
Share
x